SAN DIEGO, Calif.--(BUSINESS WIRE)--Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen delivery, today announced the opening of its European office and the addition of R. Wayne Frost, Vice President, Regulatory Affairs and Quality Assurance to the company’s management team.
